These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32297754)

  • 1. Evaluating a longitudinal mediation model of perceived stress, depressive symptoms, and substance use treatment outcomes.
    Roos CR; Kiluk BD; McHugh RK; Carroll KM
    Psychol Addict Behav; 2020 Sep; 34(6):660-668. PubMed ID: 32297754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galantamine and Computerized Cognitive Behavioral Therapy for Cocaine Dependence: A Randomized Clinical Trial.
    Carroll KM; Nich C; DeVito EE; Shi JM; Sofuoglu M
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29286595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-Blind Placebo-Controlled Trial of Galantamine for Methadone-Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use.
    Carroll KM; DeVito EE; Yip SW; Nich C; Sofuoglu M
    Am J Addict; 2019 Jul; 28(4):238-245. PubMed ID: 31165574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alexithymia level and response to computer-based training in cognitive behavioral therapy among cocaine-dependent methadone maintained individuals.
    Morie KP; Nich C; Hunkele K; Potenza MN; Carroll KM
    Drug Alcohol Depend; 2015 Jul; 152():157-63. PubMed ID: 25982006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone.
    Carroll KM; Kiluk BD; Nich C; Gordon MA; Portnoy GA; Marino DR; Ball SA
    Am J Psychiatry; 2014 Apr; 171(4):436-44. PubMed ID: 24577287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).
    Roux P; Lions C; Vilotitch A; Michel L; Mora M; Maradan G; Marcellin F; Spire B; Morel A; Carrieri PM;
    Harm Reduct J; 2016 Apr; 13():12. PubMed ID: 27048152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts.
    Petrakis I; Carroll KM; Nich C; Gordon L; Kosten T; Rounsaville B
    Drug Alcohol Depend; 1998 May; 50(3):221-6. PubMed ID: 9649975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of computerized cognitive behavioral therapy on acquisition of coping skills among cocaine-dependent individuals enrolled in methadone maintenance.
    Kiluk BD; DeVito EE; Buck MB; Hunkele K; Nich C; Carroll KM
    J Subst Abuse Treat; 2017 Nov; 82():87-92. PubMed ID: 29021121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence.
    Rass O; Umbricht A; Bigelow GE; Strain EC; Johnson MW; Mintzer MZ
    Psychol Addict Behav; 2015 Mar; 29(1):237-46. PubMed ID: 25365653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress indices in methadone maintenance treatment - Cross sectional and follow up study.
    Peles E; Malik E; Altman Y; Baharav A; Schreiber S; Sason A; Adelson M
    Psychiatry Res; 2020 Sep; 291():113218. PubMed ID: 32544714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of galantamine on cocaine use in chronic cocaine users.
    Sofuoglu M; Carroll KM
    Am J Addict; 2011; 20(3):302-3. PubMed ID: 21477060
    [No Abstract]   [Full Text] [Related]  

  • 12. Loneliness and Illicit Opioid Use Among Methadone Maintenance Treatment Patients.
    Polenick CA; Cotton BP; Bryson WC; Birditt KS
    Subst Use Misuse; 2019; 54(13):2089-2098. PubMed ID: 31232142
    [No Abstract]   [Full Text] [Related]  

  • 13. fMRI Stroop and behavioral treatment for cocaine-dependence: Preliminary findings in methadone-maintained individuals.
    DeVito EE; Kober H; Carroll KM; Potenza MN
    Addict Behav; 2019 Feb; 89():10-14. PubMed ID: 30240978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder.
    Trafton JA; Minkel J; Humphreys K
    J Stud Alcohol; 2006 Mar; 67(2):228-35. PubMed ID: 16562404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.
    Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
    Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autonomy of mood disorders among cocaine-using methadone patients.
    Rosenblum A; Fallon B; Magura S; Handelsman L; Foote J; Bernstein D
    Am J Drug Alcohol Abuse; 1999 Feb; 25(1):67-80. PubMed ID: 10078978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain, psychological flexibility, and continued substance use in a predominantly hispanic adult sample receiving methadone treatment for opioid use disorder.
    Rosen KD; Curtis ME; Potter JS
    Drug Alcohol Depend; 2020 Jan; 206():107681. PubMed ID: 31711875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in Cognitive Performance after One Year of Methadone Maintenance Treatment.
    Elkana O; Adelson M; Sason A; Doniger GM; Peles E
    Psychiatry Res; 2020 Dec; 294():113526. PubMed ID: 33126016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of Perceived Discrimination Related to Substance Use Disorders Among Patients in Methadone Maintenance Treatment.
    Nwanaji-Enwerem U; Beitel M; Oberleitner DE; Gaeta Gazzola M; Eggert KF; Oberleitner LMS; Jegede O; Zheng X; Redeker NS; Madden LM; Barry DT
    J Psychoactive Drugs; 2024; 56(4):530-540. PubMed ID: 37399330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.